Merrimack Pharmaceuticals Inc (MACK)
14.77
+0.05
(+0.34%)
USD |
NASDAQ |
Mar 27, 16:00
14.68
-0.09
(-0.61%)
After-Hours: 04:27
Merrimack Pharmaceuticals Cash from Investing (TTM): -12.45M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -12.45M |
September 30, 2023 | -12.52M |
June 30, 2023 | -8.672M |
March 31, 2023 | 0.139M |
December 31, 2022 | 0.445M |
September 30, 2022 | 0.445M |
June 30, 2022 | 0.539M |
March 31, 2022 | 0.539M |
December 31, 2021 | 0.144M |
September 30, 2021 | 0.144M |
June 30, 2021 | 0.05M |
March 31, 2021 | -0.261M |
December 31, 2020 | 2.139M |
September 30, 2020 | 7.139M |
June 30, 2020 | 13.64M |
March 31, 2020 | 42.16M |
December 31, 2019 | 69.82M |
September 30, 2019 | 54.00M |
June 30, 2019 | 73.13M |
March 31, 2019 | 49.35M |
December 31, 2018 | -22.60M |
September 30, 2018 | -6.247M |
June 30, 2018 | -36.32M |
March 31, 2018 | 535.35M |
December 31, 2017 | 576.89M |
Date | Value |
---|---|
September 30, 2017 | 583.08M |
June 30, 2017 | 635.87M |
March 31, 2017 | 81.94M |
December 31, 2016 | -3.257M |
September 30, 2016 | -13.63M |
June 30, 2016 | -38.06M |
March 31, 2016 | -34.34M |
December 31, 2015 | 75.11M |
September 30, 2015 | 36.68M |
June 30, 2015 | -27.80M |
March 31, 2015 | -13.12M |
December 31, 2014 | -6.011M |
September 30, 2014 | 17.02M |
June 30, 2014 | 6.535M |
March 31, 2014 | -8.181M |
December 31, 2013 | -27.74M |
September 30, 2013 | -29.05M |
June 30, 2013 | 36.97M |
March 31, 2013 | -63.29M |
December 31, 2012 | -75.22M |
September 30, 2012 | -61.14M |
June 30, 2012 | -76.73M |
March 31, 2012 | -3.612M |
December 31, 2011 | -3.747M |
September 30, 2011 | -2.963M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-12.52M
Minimum
Sep 2023
73.13M
Maximum
Jun 2019
14.00M
Average
0.492M
Median
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.017M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.237M |
Ampio Pharmaceuticals Inc | -- |